Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - SEQUENOM INC | d408400dex991.htm |
| EX-99.2 - UPDATED RISK FACTOR DISCLOSURE. - SEQUENOM INC | d408400dex992.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): September 10, 2012
SEQUENOM, INC.
(Exact Name of Registrant as Specified in Charter)
| DELAWARE | 000-29101 | 77-0365889 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
3595 JOHN HOPKINS COURT
SAN DIEGO, CALIFORNIA 92121
(Address of Principal Executive Offices)
(858) 202-9000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events. |
On September 10, 2012, Sequenom, Inc. (the “Company”) issued a press release titled “Sequenom Announces Proposed Offering of $100 Million of Convertible Senior Notes” (the “Launch Press Release”) announcing the launch of its private offering to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended. A copy of the Launch Press Release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
In addition, in connection with the private offering described above, the Company is filing the information set forth in Exhibit 99.2 hereto with the Securities and Exchange Commission for the purpose of updating certain aspects of its publicly disclosed description of its risk factors, including relating to certain intellectual property and regulatory issues.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| Exhibit |
Description | |
| 99.1 | Press Release, dated September 10, 2012, titled “Sequenom Announces Proposed Offering of $100 Million of Convertible Senior Notes.” | |
| 99.2 | Updated risk factor disclosure. | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SEQUENOM, INC. | ||||
| Dated: September 10, 2012 | By: | /s/ Clarke Neumann | ||
| Clarke Neumann | ||||
| Vice President and General Counsel | ||||
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press Release, dated September 10, 2012, titled “Sequenom Announces Proposed Offering of $100 Million of Convertible Senior Notes.” | |
| 99.2 | Updated risk factor disclosure. | |